Giving cats exactly what they need to be SAFE!
What makes our feline vaccines different? We use only PureVax by Merial with recombiant technology.
PureVax is the only complete line of feline vaccines that does not require adjuvants. Adjuvants can present potential risks to feline patients including:
- Site injection reaction.(1)
- Injection site granuloma.(1)
- Chronic inflammation.(1)
Combinations to fit any protocol.
Why allow risk at all from adjuvants? With the strong immunostimulation provided by PureVax modified-live and recombinant vaccines, adjuvants are simply not needed.
What recombinant technology means to you:
Excellent safety
- No pathogenic cirus in vaccine
- No risk of reversion to virulence
- No adjuvants
Powerful immunogenicity.
- Rapid, comprehensive immune response, including both humoral and cell-mediated immunity.(3)
- Expresses protein antigens in natural form.(3)
The most advanced choices.
- PureVax modified-live and recombinant vaccines gives the rapid, comprehensive immune response your pets need.
- Killed vaccines cannot stimulate lasting immunity without adjuvants.(2)
- Killed vaccines cannot deliever the strength of immunity of modified-live and recombinant vaccines.(2)
The efficacy of modified-live vaccines: Modified live vaccine fractions in the PureVax line have clear advantages over killed vaccines.
- Induce cell-mediated immunity and humoral (antibody) response.(2)
- Require no adjuvants.(2)
- Provide rapid protection.(2)
- Require lower antigen mass(2)
Extra PEACE OF MIND for deadly rabies and feline leukemia.
PureVax Feline Rabies and Recombinant Leukemia Vaccine are canarypox-vectored recombinants, using the most advanced vaccine technology available. It delievers only the proteins absolutely needed for protection. This targeted action further reduces risk by not exposing cats to the whole virus.
Feline Leukemia VET JET™ 
Feline Leukemia VET JET™ transdermal vaccination system provides broad dispersion of vaccine throughout tissue-rich immune cells.
(Read about the canine vaccines used at Animal Health Services here.)
1. Macy DW. The Potential Role and Mechanisms of FeLV Vaccine-Induced
Neoplasms. Seminars in Vet Medicine and Surgery (Small Animal)1995;
10(4): 234-237.
2. Greene CE and Schultz RD, Chapter 100: Immunoprophylaxis in
Infectious Diseases of Dog and Cat. Philadelphia: WB Saunders
Co.,2006:1069-1119.
3. Data on file at Merial.
